Sialic acid moiety (None commonly used; “Sia” is sometimes used informally but not standardized for the moiety.)

Sialic acid moieties are a family of negatively charged, nine-carbon monosaccharide residues (typically N-acetylneuraminic acid, Neu5Ac) commonly found attached to the terminal ends of glycoproteins and glycolipids on cell surfaces[1][2][3][6]. Sialylation—the enzymatic addition of sialic acids—is a key post-translational modification that influences cell signaling, molecular stability, recognition by the immune system, and interactions with pathogens. Sialic acid moieties are essential for normal development, especially in the nervous and immune systems, and play prominent roles in disease processes such as cancer, infection (as viral or bacterial entry receptors), and autoimmunity. While "sialic acid moieties" are not themselves drug targets, their biological relevance is exploited in various therapies and diagnostics by targeting their associated enzymes or binding interactions[1][2][5][7].

Other names

Sialyl groupSia residueTerminal sialic acidSialylated glycanSialic acid terminus

Enzyme inhibition (sialyltransferases, sialidases); Competitive antagonism to sialic acid-binding proteins (e.g., blocking viral hemagglutinin interaction); Modulating immune response (altering sialylation on IgG for anti-inflammatory effect)